Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classification

IF 3.4 2区 医学 Q1 PATHOLOGY
Yedong Mi, Donglai Chen, Zhangqiang Chen, Yue Li, Xiaoxiao Dai, Shanshan Shen, Jian Shu, Yongzhong Li, Lijie Tan, Yiming Mao, Qifeng Ding, Yongbing Chen
{"title":"Which descriptor should spread through air spaces (STAS) be incorporated into? T descriptor versus residual tumor classification","authors":"Yedong Mi,&nbsp;Donglai Chen,&nbsp;Zhangqiang Chen,&nbsp;Yue Li,&nbsp;Xiaoxiao Dai,&nbsp;Shanshan Shen,&nbsp;Jian Shu,&nbsp;Yongzhong Li,&nbsp;Lijie Tan,&nbsp;Yiming Mao,&nbsp;Qifeng Ding,&nbsp;Yongbing Chen","doi":"10.1002/2056-4538.70039","DOIUrl":null,"url":null,"abstract":"<p>It has not been determined which descriptor spread through air spaces (STAS) should be incorporated into the context of the ninth Tumor, Node and Metastasis (TNM) staging system: the T or the uncertain resection [R(un)] category. A multicenter retrospective cohort of 807 patients with pathological stage I lung adenocarcinoma was included in this study to assess the feasibility of incorporating STAS into the T descriptor or the R(un) category by analyzing recurrence-free survival (RFS) and overall survival (OS). Decision curve analysis (DCA) was performed to evaluate the standardized net benefit of the proposed T (nT) and that of the proposed residual tumor classification (nR) versus the current staging systems. Log-rank tests indicated that patients with pT1/STAS-positive lung adenocarcinoma had similar RFS and OS to patients with pT2a disease irrespective of R status. Regarding STAS as an indicator for upgrading R0 to R(un), comparable survival was observed between pT1-2a/STAS-positive patients undergoing R0 segmentectomy and pT1-2a patients undergoing R(un) segmentectomy. We further assessed the effects of the combination of STAS with either T or R category on survival in a validation cohort. Subgroup analyses stratified by surgical procedures further identified the consistency of the nT category in discriminating RFS and OS. However, the separation of nR0 and nR(un) disease in pT2a tumors treated by lobectomy or segmentectomy was not sufficiently distinguished. DCA further corroborated a greater predictive capability of nT versus the current T category. In conclusion, STAS might be preferentially considered as an indicator for upgrading pT1 disease into pT2a in the future TNM staging system.</p>","PeriodicalId":48612,"journal":{"name":"Journal of Pathology Clinical Research","volume":"11 4","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/2056-4538.70039","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pathology Clinical Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/2056-4538.70039","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

It has not been determined which descriptor spread through air spaces (STAS) should be incorporated into the context of the ninth Tumor, Node and Metastasis (TNM) staging system: the T or the uncertain resection [R(un)] category. A multicenter retrospective cohort of 807 patients with pathological stage I lung adenocarcinoma was included in this study to assess the feasibility of incorporating STAS into the T descriptor or the R(un) category by analyzing recurrence-free survival (RFS) and overall survival (OS). Decision curve analysis (DCA) was performed to evaluate the standardized net benefit of the proposed T (nT) and that of the proposed residual tumor classification (nR) versus the current staging systems. Log-rank tests indicated that patients with pT1/STAS-positive lung adenocarcinoma had similar RFS and OS to patients with pT2a disease irrespective of R status. Regarding STAS as an indicator for upgrading R0 to R(un), comparable survival was observed between pT1-2a/STAS-positive patients undergoing R0 segmentectomy and pT1-2a patients undergoing R(un) segmentectomy. We further assessed the effects of the combination of STAS with either T or R category on survival in a validation cohort. Subgroup analyses stratified by surgical procedures further identified the consistency of the nT category in discriminating RFS and OS. However, the separation of nR0 and nR(un) disease in pT2a tumors treated by lobectomy or segmentectomy was not sufficiently distinguished. DCA further corroborated a greater predictive capability of nT versus the current T category. In conclusion, STAS might be preferentially considered as an indicator for upgrading pT1 disease into pT2a in the future TNM staging system.

Abstract Image

哪个描述符应该包含在空气空间(STAS)中?T描述符与残余肿瘤分类
目前尚未确定哪种描述符通过空气间隙扩散(STAS)应纳入第九种肿瘤、淋巴结和转移(TNM)分期系统:T或不确定切除[R(un)]类别。本研究纳入了807例病理I期肺腺癌患者的多中心回顾性队列,通过分析无复发生存期(RFS)和总生存期(OS)来评估将STAS纳入T描述符或R(un)类别的可行性。进行决策曲线分析(DCA)来评估建议的T (nT)和建议的残余肿瘤分类(nR)相对于当前分期系统的标准化净收益。Log-rank检验表明,无论R状态如何,pT1/ stas阳性肺腺癌患者的RFS和OS与pT2a患者相似。将STAS作为R0升级到R(un)的指标,在接受R0节段切除术的pT1-2a/STAS阳性患者与接受R(un)节段切除术的pT1-2a患者之间观察到相当的生存率。在验证队列中,我们进一步评估了STAS与T或R类别组合对生存的影响。按手术方式分层的亚组分析进一步确定了nT分类在区分RFS和OS方面的一致性。然而,经肺叶切除术或节段切除术治疗的pT2a肿瘤中nR0和nR(un)疾病的分离并没有得到充分的区分。DCA进一步证实了nT与目前的T类别相比具有更大的预测能力。综上所述,在未来的TNM分期系统中,STAS可能优先考虑作为pT1疾病升级为pT2a的指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Pathology Clinical Research
Journal of Pathology Clinical Research Medicine-Pathology and Forensic Medicine
CiteScore
7.40
自引率
2.40%
发文量
47
审稿时长
20 weeks
期刊介绍: The Journal of Pathology: Clinical Research and The Journal of Pathology serve as translational bridges between basic biomedical science and clinical medicine with particular emphasis on, but not restricted to, tissue based studies. The focus of The Journal of Pathology: Clinical Research is the publication of studies that illuminate the clinical relevance of research in the broad area of the study of disease. Appropriately powered and validated studies with novel diagnostic, prognostic and predictive significance, and biomarker discover and validation, will be welcomed. Studies with a predominantly mechanistic basis will be more appropriate for the companion Journal of Pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信